Preliminary Evaluation of a New Initiative to Centralize Colorectal Cancer Care During the COVID-19 Epidemic in Shanghai, China: A Retrospective Study

2021 ◽  
Author(s):  
Jiaoling Huang ◽  
Rui Liu ◽  
Xuejing Yu ◽  
Zheng Wang ◽  
Xueyun Zeng ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Retrospective Study ◽  
Cancer Care ◽  
Preliminary Evaluation

The survival after recurrence of colorectal cancer: a retrospective study focused on time to recurrence after curative resection

Surgery Today ◽  
2021 ◽  
Author(s):  
Hirotaka Furuke ◽  
Tomohiro Arita ◽  
Yoshiaki Kuriu ◽  
Hiroki Shimizu ◽  
Jun Kiuchi ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Retrospective Study ◽  
Curative Resection ◽  
Time To Recurrence

scholarly journals Effect of the COVID-19 pandemic on colorectal cancer care in France

2021 ◽  
Vol 6 (5) ◽  
pp. 342-343
Author(s):  
Sonia Priou ◽  
Guillaume Lamé ◽  
Gilles Chatellier ◽  
Christophe Tournigand ◽  
Emmanuelle Kempf
Keyword(s):  
Colorectal Cancer ◽  
Cancer Care

Guideline-recommended incorporation of biomarker testing results in metastatic colorectal cancer therapy

2020 ◽  
Vol 17 (3) ◽  
pp. 185-194
Author(s):  
Jared Freml ◽  
Thomas Delate ◽  
Jesus Hermosillo-Rodriguez
Keyword(s):  
Colorectal Cancer ◽  
Retrospective Study ◽  
Cancer Therapy ◽  
Metastatic Colorectal Cancer ◽  
Small Proportion ◽  
Biomarker Testing ◽  
Over Time

Aim: To describe pharmacogenomic tumor testing among patients with metastatic colorectal cancer. Methods: This was a retrospective study of patients with metastatic colorectal cancer diagnosed between 1 January 2014 and 30 June 2018. Patients were assessed for pharmacogenomic testing and appropriateness of chemotherapy use. Results: Overall, 112/167 (67.1%) patients had at least one of the three recommended pharmacogenomic tests and 41/167 (24.6%) had all tests. Twenty-four patients were treated with cetuximab with 8/167 (4.7%) identified as being treated with a RAS variant (n = 3) or incomplete testing (n = 5); thus, not in accordance with guidelines. Conclusion: Uptake of testing was variable but increased over time; however, a small proportion of patients received cetuximab with a variant or not all recommended tests being performed.

General surgeons’ views on Oncologic Multidisciplinary Group meetings as part of colorectal cancer care

2012 ◽  
Vol 64 (4) ◽  
pp. 273-278 ◽  
Author(s):  
Francesco Feroci ◽  
Elisa Lenzi ◽  
Maddalena Baraghini ◽  
Stefano Cantafio ◽  
Marco Scatizzi
Keyword(s):  
Colorectal Cancer ◽  
Cancer Care ◽  
General Surgeons ◽  
Multidisciplinary Group ◽  
Group Meetings

Evidence-Based and Clinical Outcome Scores to Facilitate Audit and Feedback for Colorectal Cancer Care

2009 ◽  
Vol 52 (4) ◽  
pp. 616-622 ◽  
Author(s):  
Miriam R. Habib ◽  
Michael J. Solomon ◽  
Jane M. Young ◽  
Bruce K. Armstrong ◽  
Dianne O'Connell ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Clinical Outcome ◽  
Cancer Care ◽  
Audit And Feedback ◽  
Evidence Based ◽  
Outcome Scores

ID: 3523886 LONG-TERM OUTCOMES AND SURVIVAL AFTER ENDOSCOPIC OR SURGICAL RESECTION FOR T1 COLORECTAL CANCER: A MULTICENTER RETROSPECTIVE STUDY

2021 ◽  
Vol 93 (6) ◽  
pp. AB86
Author(s):  
Hirohito Tanaka ◽  
Shiko Kuribayashi ◽  
Masanori Sekiguchi ◽  
Atsuo Iwamoto ◽  
Yoko Hachisu ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Retrospective Study ◽  
Surgical Resection ◽  
Long Term Outcomes ◽  
T1 Colorectal Cancer

Multidisciplinary Management of Colorectal Cancer Brain Metastases: A Retrospective Study

2007 ◽  
Vol 69 (3) ◽  
pp. S250
Author(s):  
T.J. Kruser ◽  
S.T. Chao ◽  
P. Elson ◽  
G.H. Barnett ◽  
M. Vogelbaum ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Retrospective Study ◽  
Brain Metastases ◽  
Multidisciplinary Management
Sign in / Sign up

Export Citation Format

Share Document